Cargando…

Factors Affecting Effectiveness of Fecal Microbiota Transplant

BACKGROUND: Fecal microbiota transplant (FMT) is an effective treatment for relapsing Clostridium difficile infection (CDI). With more widespread use of this intervention, variable cure rates (70–95%) have been observed. We conducted this study to identify specific patient- and procedure-level facto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mosby, Danielle, Mcgraw, Patty, Duffalo, Chad, Drees, Marci, Depalma, Fedele, Herdman, Christine, Myerson, Scott, Bacon, Alfred E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631128/ http://dx.doi.org/10.1093/ofid/ofx163.959

Ejemplares similares

Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
por: Hussam, Dina, et al.
Publicado: (2017)

624. Microbiota and Associations with Treatment Outcome in Fecal Microbiota Transplantation
por: Bogdanovich, Tatiana, et al.
Publicado: (2018)

Engraftment and Augmentation of Microbiome Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Lee, Christine, et al.
Publicado: (2017)

2760. Fecal Microbiota Transplantation for Decolonization of Carbapenemase-Producing Enterobacterales
por: Davido, Benjamin, et al.
Publicado: (2023)

312. Strain Engraftment and Gene Transfer in a Fecal Microbiota Transplantation Cohort
por: Brink, Catherine, et al.
Publicado: (2023)

515. Comparing Different Delivery Methods of Fecal Microbiota Transplantation
por: Lee, Eun Hwa, et al.
Publicado: (2022)

Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017)

2584. Effects of Fecal Microbiota Transplantation for Decolonizing Multidrug-Resistant Organism
por: Seong, Hye, et al.
Publicado: (2019)

167. Deep Space Infections in Injection Drug Users (IDU)
por: Bacon, Alfred Emmanuel, et al.
Publicado: (2019)

618. Do Clinical Factors Affect Microbial Engraftment After Fecal Microbiota Transplantation in Recurrent Clostridium difficile Infection?
por: Budree, Shrish, et al.
Publicado: (2018)

615. Can We Restore the Lung Microbiome with Fecal Microbiota Transplant (FMT)?
por: Mendez, Roberto, et al.
Publicado: (2018)

286. The Effect of Fecal Microbiota Transplantation on Decolonization of Multidrug-resistant Organisms in the gut
por: Soon Lee, Seung, et al.
Publicado: (2023)

Prospective, Open-label Trial to Evaluate Efficacy of Lyophilized Fecal Microbiota Transplantation for Treatment of Recurrent C. difficile Infection
por: Goldeh, Peyman, et al.
Publicado: (2017)

90. Fecal Microbiota Transplantation in Metastatic Melanoma Patients Resistant to Anti-PD-1 Treatment
por: Youngster, Ilan, et al.
Publicado: (2019)

Age-related Aortic Stiffness Can Be Transferred and Ameliorated via Fecal Microbiota Transplant in Mice.
por: Greenberg, Nathan, et al.
Publicado: (2021)

1122. Evaluation of Fecal Microbiota Transplant (FMT) in Elderly Patients With recurrent Clostridium difficile Infection (CDI)
por: Hassoun, Ali, et al.
Publicado: (2018)

2432. Durability Against Antibiotics After Response to Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Saha, Srishti, et al.
Publicado: (2019)

2436. Real-world Evidence of Fecal Microbiota Transplant Use and Outcomes in Patients with Clostridioides difficile Infection
por: Nelson, Winnie, et al.
Publicado: (2019)

Fecal Microbiota Transplantation: Is It Safe?
por: Park, Seon-Young, et al.
Publicado: (2021)

Impact of Fecal Microbiota Transplantation on Digestive Tract Colonization due to Carbapenem-resistant Enterobacteriacae and Vancomycin-resistant Enterococci
por: Davido, Benjamin, et al.
Publicado: (2017)

109. Differences in Gram-Negative Antibiotic Susceptibility Among Patients Receiving Fecal Microbiota Transplant for Clostridioides difficile
por: Woodworth, Michael, et al.
Publicado: (2018)

533. Scaling Pediatric Access to Fecal Microbiota Transplantation in the United States: A Time-Series Geospatial Analysis
por: Panchal, Pratik, et al.
Publicado: (2018)

2517. Oral Fecal Microbiota Transplantation Increases Gut Microbiome Diversity and Alters the Microbiome Distribution in People with HIV
por: Utay, Netanya S, et al.
Publicado: (2019)

Fecal Microbiota Transplants Annually and Their Positive Clinical Impact
por: Mamoon, Lamia, et al.
Publicado: (2020)

Durability and Long-Term Clinical Outcomes of Fecal Microbiota Transplant (FMT) Treatment in Patients with Recurrent C. difficile Infection
por: Mamo, Yafet, et al.
Publicado: (2017)

1929. Evaluating Disparities in Recurrent Clostridioides difficile Infection (CDI) and Fecal Microbiota Transplant (FMT) Treatment using Geospatial and Social Vulnerability Analytic Tools
por: Little, Keighly, et al.
Publicado: (2023)

Fecal microbiota transplantation: the state of the art
por: Di Bella, Stefano, et al.
Publicado: (2013)

Fecal Microbiota Transplant: Benefits and Risks
por: Weil, Ana A., et al.
Publicado: (2015)

Clinical Usefulness of Fecal Microbiota Transplantation
por: Park, Jung Ho
Publicado: (2017)

Fecal Microbiota Transplantation in Neurological Disorders
por: Vendrik, Karuna E. W., et al.
Publicado: (2020)

Next Generation Fecal Microbiota Transplantation
por: Gweon, Tae-Geun, et al.
Publicado: (2021)

Fecal microbiota transplantation – where are we?
por: Mikolašević, Ivana, et al.
Publicado: (2021)

Fecal Microbiota Transplantation: What’s New?
por: Masucci, Luca, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in NAFLD Treatment
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Fecal Microbiota Transplantation in Liver Cirrhosis
por: Boicean, Adrian, et al.
Publicado: (2023)

An ecological framework to understand the efficacy of fecal microbiota transplantation
por: Xiao, Yandong, et al.
Publicado: (2020)

Fecal Microbiota Transplantation and the Brain Microbiota in Neurological Diseases
por: Ruggiero, Marco
Publicado: (2016)

1497. Relapsing Clostridium difficile Infection: Resolution with Combined Patient Choice Fecal Microbiota Transplantation, Vancomycin Taper, and Vancomycin Suppression
por: Shadowen, Rebecca D, et al.
Publicado: (2019)

792. Evaluation of Persistent Diarrhea and Recurrence Following Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
por: Boton, Noah, et al.
Publicado: (2020)

Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank
por: Seo, Hyun Soo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_at4v6ahot7tuhno567ovmdv2i1